Vimarsana
Biggest News Aggregation in the World

Page 3 - Techne Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Techne Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Techne Corp Today - Breaking & Trending Today

Fetal Bovine Serum Market will Accelerate at a CAGR of 5.44% due to Strategic Alliances Among Vendors - Vimarsana News

Fetal Bovine Serum Market will Accelerate at a CAGR of 5.44% due to Strategic Alliances Among Vendors

/PRNewswire/ -- The latest market analysis report titled Fetal Bovine Serum Market by Application and Geography - Forecast and Analysis 2022-2026 has been...

Envoy Medical, Mayo Clinic starting feasibility study for ear implant - Vimarsana News

Envoy Medical, Mayo Clinic starting feasibility study for ear implant

Acclaim cochlear device is aimed at patients with severe hearing loss.

Techne: Fiscal Q1 Earnings Snapshot - Vimarsana News

Techne: Fiscal Q1 Earnings Snapshot

MINNEAPOLIS (AP) _ Techne Corp. (TECH) on Tuesday reported fiscal first-quarter earnings...

Techne: Fiscal Q1 Earnings Snapshot - Vimarsana News

Techne: Fiscal Q1 Earnings Snapshot

MINNEAPOLIS (AP) _ Techne Corp. (TECH) on Tuesday reported fiscal first-quarter earnings of $69.6 million.

Source: wxow.com
Is It Too Late to Buy Bio-Techne (TECH) Stock? - Vimarsana News

Is It Too Late to Buy Bio-Techne (TECH) Stock?

Is It Too Late to Buy Bio-Techne (TECH) Stock? Baron Asset Fund recently published its first-quarter commentary – a copy of which can be downloaded here. During the first quarter of 2021, the Baron Asset Fund returned -1.03% (institutional shares). In comparison, the benchmark S&P 500 Index was up 6.17%, while the Russell Midcap Growth Index was down 0.57%. You should check out Baron Asset Fund’s top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021. In the Q1 2021 Investor Letter, the fund highlighted a few stocks and Bio-Techne Corp (NASDAQ:TECH) i...